Complete Filing Data
Baird Medical Investment Holdings Ltd reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $39.76 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Baird Medical Investment Holdings Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Selling And Marketing Expense | $4.1M | $2.5M | $3.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $37.0M | $31.5M | $35.1M |
| Research And Development Expense | $6.2M | $4.3M | $3.9M |
| Profit Loss | $12.6M | $10.7M | $12.8M |
| Other Nonoperating Income Expense | -$651.7K | -$10.2K | -$194.6K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $11.5M | $9.9M | $11.3M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.1M | -$728.7K | -$1.5M |
| Operating Income Loss | $15.3M | $11.9M | $13.6M |
| Operating Expenses | $17.3M | $15.4M | $14.4M |
| Net Income Losses Attributable To Parent | $12.5M | $10.5M | $12.6M |
| Net Income Loss Attributable To Noncontrolling Interest | $144.7K | $112.2K | $206.2K |
| Interest Expense Nonoperating | $576.8K | $285.8K | $299.3K |
| Income Taxes Paid Net | $1.8M | $2.6M | $1.4M |
| Income Tax Expense Benefit | $1.5M | $1.7M | $1.7M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $14.1M | $12.4M | $14.5M |
| Gross Profit | $32.7M | $27.2M | $28.0M |
| Government Assistance Nonoperating Income | $266.00 | $792.0K | $1.4M |
| General And Administrative Expense | $7.1M | $8.5M | $7.0M |
| Deferred Income Tax Expense Benefit | $32.8K | -$542.0K | -$143.3K |
| Cost Of Revenue | $4.4M | $4.2M | $7.1M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $144.7K | $112.2K | $206.2K |
| Comprehensive Income Net Of Tax | $11.3M | $9.8M | $11.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity * | $39.7M | $35.8M | $25.8M | $14.5M |
| Short Term Bank Loans And Notes Payable | $16.2M | $58.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.0M | $1.5M | $1.7M | $3.0M |
| Repayments Of Bank Debt | $11.0M | $7.5M | $4.6M | |
| Operating Lease Right Of Use Asset Amortization Expense | $368.3K | $366.4K | $553.9K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.5M | -$200.4K | -$1.3M | |
| Taxes Payable Current | $2.9M | $771.0K | ||
| Retained Earnings Accumulated Deficit | $26.8M | $14.4M | ||
| Repayments Of Long Term Debt | $806.8K | $194.0K | ||
| Property Plant And Equipment Net | $7.1M | $6.1M | ||
| Other Receivables Net Current | $2.9K | $394.6K | ||
| Other Liabilities Current | $3.7M | $3.8M | ||
| Operating Lease Right Of Use Asset | $475.1K | $861.3K | ||
| Operating Lease Liability Noncurrent | $136.7K | $412.1K | ||
| Operating Lease Liability Current | $264.3K | $503.9K | ||
| Minority Interest | $101.3K | -$43.4K | ||
| Long Term Debt Noncurrent | $3.4M | $1.6M | ||
| Long Term Debt Current | $867.8K | $817.5K | ||
| Liabilities Noncurrent | $3.6M | $2.0M | ||
| Liabilities Current | $34.6M | $19.0M | ||
| Liabilities And Stockholders Equity | $78.0M | $56.7M | ||
| Liabilities | $38.2M | $21.0M | ||
| Inventory Net | $1.3M | $1.1M | ||
| Intangible Assets Net Excluding Goodwill | $16.5K | $25.5K | ||
| Goodwill | $57.8K | $59.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Proceeds From Bank Debt | $19.3M | $9.6M | $9.1M |
| Payments To Due To Related Parties | -$407.5K | $182.0K | $347.9K |
| Payments To Acquire Property Plant And Equipment | $2.9M | $2.6M | $5.9M |
| Net Cash Provided By Used In Operating Activities | -$6.3M | -$1.0M | $486.0K |
| Net Cash Provided By Used In Investing Activities | -$2.9M | -$2.6M | -$5.9M |
| Net Cash Provided By Used In Financing Activities | $10.7M | $3.5M | $4.4M |
| Increase Decrease In Prepaid Expense | $4.7M | $5.3M | $3.6M |
| Increase Decrease In Operating Lease Liability | -$497.4K | -$253.6K | $389.5K |
| Increase Decrease In Inventories | $187.5K | -$113.7K | -$1.6M |
| Increase Decrease In Deposits And Other Assets | -$153.9K | -$149.8K | $115.1K |
| Increase Decrease In Contract With Customer Liability | $310.2K | -$173.1K | $45.4K |
| Increase Decrease In Accrued Taxes Payable | $2.2M | -$972.5K | $1.1M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.6M | $1.2M | $1.3M |
| Increase Decrease In Accounts Receivable | $17.8M | $9.7M | $14.8M |
| Increase Decrease In Accounts Payable | $727.8K | $341.5K | -$100.9K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$94.3K | -$3.1K | -$297.6K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 25.6M | 25.6M | 25.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 25.6M | 25.6M | 25.6M |
| Earnings Per Share Diluted | $0.49 | $0.41 | $0.49 |
| Earnings Per Share Basic | $0.49 | $0.41 | $0.49 |
| Preferred Stock Shares Outstanding | 290.0K | 0.00 | |
| Preferred Stock Shares Issued | 290.0K | 0.00 | |
| Preferred Stock Shares Authorized | 5.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Investment Income Interest | $393.00 | $1.6K | $8.6K |
| Interest Paid Net | $497.2K | $261.3K | $243.8K |
| Depreciation And Amortization | $1.1M | $1.0M | $916.1K |
| Appropriation Of Statutory Reserve | $80.0K | $100.0K | $1.4M |
| Statutory Reserve | $4.6M | $4.5M | |
| Prepaid Expense Noncurrent | $8.0M | $7.7M | |
| Prepaid Expense Current | $10.3M | $5.8M |
Most recent annual filing with the SEC: May 15, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.